secwatch.observer — SEC 8-K summary
======================================

Issuer:     INSMED Inc (INSM)
CIK:        0001104506
Form:       8-K
Filed at:   2025-04-17T23:59:59+00:00
Accession:  0001140361-25-014376
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Insmed CCO J. Drayton Wise resigns effective immediately for medical reasons; stays as consultant
--------------------------------------------------------------------------------

- J. Drayton Wise resigned as Chief Commercial Officer effective April 16, 2025, for personal and medical reasons, unrelated to operations.
- He will provide consulting services through December 31, 2025, with automatic two three-month extensions unless mutually terminated.
- Consulting fee: $30,000/month during initial period; $20,000/month during extensions. Outstanding equity awards continue to vest.
- No replacement named; Wise will support transition under a consulting agreement. Options exercisable for 3 months post-service or original 10-year expiry.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1104506/000114036125014376/0001140361-25-014376-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1104506/000114036125014376/ef20047566_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-014376

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer